CAS RN: 1393465-84-3

PLX7904

Product Availability

Choose a grade to view its available package options.

7 package records3 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250428 100mg Out of stock Inquiry
Batchno.20260607 10mg In stock Shanghai Inquiry
Batchno.20260121 25mg Out of stock Inquiry
Batchno.20260113 2mg In stock Shanghai Inquiry
Batchno.20251120 50mg Out of stock Inquiry
Batchno.20250620 5mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260303 1mg / 5mg / 25mg Out of stock 5-7 business days Inquiry
  • Product code: starshine_CAS1393465-84-3
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1393465-84-3 / 5-(2-cyclopropylpyrimidin-5-yl)-3-[3-[[ethyl(methyl)sulfamoyl]amino]-2,6-difluorobenzoyl]-1H-pyrrolo[2,3-b]pyridine

Standard CAS: 1393465-84-3 Multi CAS: No

Basic Information

CAS
1393465-84-3
Multi CAS
No
Molecular Formula
C24H22F2N6O3S
Molecular Weight
512.500000
Exact Mass
512.144216
SMILES
CCN(C)S(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CN=C(N=C4)C5CC5)F
InChI
InChI=1S/C24H22F2N6O3S/c1-3-32(2)36(34,35)31-19-7-6-18(25)20(21(19)26)22(33)17-12-30-24-16(17)8-14(9-29-24)15-10-27-23(28-11-15)13-4-5-13/h6-13,31H,3-5H2,1-2H3,(H,29,30)
InChIKey
DKNZQPXIIHLUHU-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
36
Aromatic heavy atom count
21
Fraction Csp3
0.25
Rotatable bonds
8
H-bond acceptors
6
H-bond donors
2
Molar refractivity
129.73
TPSA
120.94

LogP / Solubility

WLOGP
4.01
MLOGP
3.57
XLogP3
2.6
Consensus LogP
3.39
Log S (ESOL)
-5.45
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.66
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.28
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
5

Get In Touch

Contact Us